Tempus Ai Class Stock Today
| TEM Stock | 66.27 2.09 3.06% |
PerformanceWeakest
| Odds Of DistressLow
|
Tempus AI is selling at 66.27 as of the 10th of January 2026; that is 3.06 percent decrease since the beginning of the trading day. The stock's lowest day price was 66.17. Tempus AI has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of December 2025 and ending today, the 10th of January 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 14th of June 2024 | Category Healthcare | Classification Health Care |
Tempus AI is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 172.86 M outstanding shares of which 18.11 M shares are at this time shorted by investors with about 4.59 days to cover. More on Tempus AI Class
Moving together with Tempus Stock
Moving against Tempus Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Tempus Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO, CoFounder | Eric Lefkofsky | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Tembo Gold Corp | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Nasdaq CTA Artificial, NASDAQ Biotechnology, NASDAQ Composite, Health Care, Life Sciences Tools & Services, Internet Content & Information, Communication Services (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsTempus AI can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Tempus AI's financial leverage. It provides some insight into what part of Tempus AI's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tempus AI Class (TEM) is traded on NASDAQ Exchange in USA and employs 2,400 people. Tempus AI is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 12.16 B. Tempus AI Class runs under Life Sciences Tools & Services sector within Health Care industry. The entity has 172.86 M outstanding shares of which 18.11 M shares are at this time shorted by investors with about 4.59 days to cover.
Tempus AI generates negative cash flow from operations
Check Tempus AI Probability Of Bankruptcy
Ownership AllocationTempus AI Class shows a total of 172.86 Million outstanding shares. Over half of Tempus AI's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Tempus Ownership Details
Tempus AI Historical Income Statement
Tempus Stock Against Markets
Tempus AI Corporate Management
| Ryan Fukushima | Chief Officer | Profile | |
| Stacey Kraft | Chief Officer | Profile | |
| Shane Colley | Chief Officer | Profile | |
| Patty Spiller | Senior Marketing | Profile | |
| Nike MD | Senior Pathology | Profile | |
| Christina Antoniou | Senior Development | Profile | |
| Ryan Bartolucci | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tempus AI Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tempus AI. If investors know Tempus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tempus AI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share | Quarterly Revenue Growth 0.847 | Return On Assets | Return On Equity |
The market value of Tempus AI Class is measured differently than its book value, which is the value of Tempus that is recorded on the company's balance sheet. Investors also form their own opinion of Tempus AI's value that differs from its market value or its book value, called intrinsic value, which is Tempus AI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tempus AI's market value can be influenced by many factors that don't directly affect Tempus AI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tempus AI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tempus AI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tempus AI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.